Picture of AngioDynamics logo

ANGO — AngioDynamics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

AngioDynamics Inc expected to post a loss of 7 cents a share - Earnings Preview

* AngioDynamics Inc  ANGO.OQ   ANGO.O  is expected to show a
fall
in quarterly revenue when it reports  results on January 5 for
the period ending August 31 2023
    * The Latham New York-based  company is expected to report a
4.0% decrease in revenue to $82.04 million from $85.43 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for AngioDynamics Inc is for
a
loss of 7 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
AngioDynamics Inc
is $19.00​, above​ its last closing price of $8.03. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Aug. 31 2023  -0.13       -0.13      -0.12     Beat    7.7
 May. 31 2023  0.03        0.02       0.02      Met     -11.1
 Feb. 28 2023  -0.01       -0.01      -0.03     Missed  -300​
 Nov. 30 2022  -0.01       -0.01      0.01      Beat    200
 ​​Aug.        -0.02       -0.02      -0.06     Missed  -166.7
 31 2022                                                
 May. 31 2022  0.01        0.01       0.01      Met     33.3​
 Feb. 28 2022  -0.01       -0.01      0.03      Beat    340
 Nov. 30 2021  0.00        0.01       -0.02     Missed  -481
 This summary was machine generated January 3 at 13:32 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on AngioDynamics

See all news